A-ProX, a spinout based on the group discoveries and supported by King's Spinout Accelerator Program

A-ProX is developing and applying plug-in platform technologies, comparable to Lego Game pieces, to create a range of innovative therapeutics. This solution addresses the global challenge presented by viral pandemics and the current high carbon dioxide emission produced by the pharmaceutical industry.

See news release from King's Accelecrator Program here.